HUMINSULIN N CARTIDGE (100IU) (Insulin Isophane (100IU/ml))

Huminsulin N 100 IU/ml Cartridge is indicated for the management of blood glucose levels in both adults and pediatric patients diagnosed with type 1 or type 2 diabetes. This medication is classified as an intermediate-acting insulin, which functions by lowering blood sugar concentrations in the body, thereby minimizing the risk of serious diabetes-related complications. Typically, this insulin formulation may be utilized in conjunction with short-acting insulins or other oral antidiabetic agents to achieve optimal glycemic control. It is imperative that patients receive proper instruction from healthcare professionals regarding the subcutaneous administration technique. Abrupt discontinuation of this medication should only occur under a physician’s guidance. Huminsulin N is intended to be part of a comprehensive diabetes management plan that includes adhering to a nutritious diet, engaging in regular physical activity, and achieving weight management as per the healthcare provider’s recommendations. Routine monitoring of blood glucose levels is crucial; patients should diligently record their readings and communicate this information to their healthcare team to determine the appropriate dosage tailored to their needs. Hypoglycemia, or low blood sugar, is the most frequently encountered adverse effect associated with this treatment. To mitigate this risk, it is essential to administer the precise prescribed dosage, maintain consistent meal patterns, and conduct regular blood glucose assessments. Excessive alcohol intake can further exacerbate the risk of hypoglycemia. Potential side effects may include localized reactions at the injection site, such as redness or swelling, and prolonged use can lead to lipodystrophy at the site of repeated injections. Weight gain and fluid retention, resulting in edema, may also occur in some individuals receiving insulin therapy. This medication should not be utilized by individuals experiencing hypoglycemia. Patients should inform their healthcare provider about any prior kidney, liver, or cardiac conditions before commencing treatment. It is also recommended that pregnant or breastfeeding women consult their physician, as dosage adjustments may be necessary.